HOXB13 and neoplasm: To quantify CasRx‐mediated HoxB13 knockdown efficiency at the cellular level, the pathological examination was performed using H&E staining to identify CRPC tumor cells and HoxB13 immunostaining to assess HOXB13 protein expression on the same slide and within the same field.